Simon Baker
Stock Analyst at Redburn Atlantic
(0.27)
# 4,373
Out of 5,090 analysts
8
Total ratings
25%
Success rate
-12.15%
Average return
Main Sectors:
Stocks Rated by Simon Baker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Upgrades: Buy | $13 | $1.57 | +728.03% | 1 | Nov 15, 2024 | |
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $95.99 | +77.10% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $47.08 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $125.40 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $74.86 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | $29 → $24 | $67.56 | -64.47% | 1 | Apr 8, 2020 |
Autolus Therapeutics
Nov 15, 2024
Upgrades: Buy
Price Target: $13
Current: $1.57
Upside: +728.03%
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $95.99
Upside: +77.10%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $47.08
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $125.40
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $74.86
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: $29 → $24
Current: $67.56
Upside: -64.47%